Liquid biopsy has revolutionized the management of cancer patients. In particular, liquid
biopsy-based testing has proven to be highly beneficial for identifying actionable cancer …

Lung cancer is the second most prevalent cancer and the leading cause of cancer‐related
death worldwide. Surgery, chemotherapy, molecular targeted therapy, immunotherapy, and …

Tyrosine kinase receptors (TKR) comprise more than 60 molecules that play an essential
role in the molecular pathways, leading to cell survival and differentiation. Consequently …

Abstract Purpose: Telisotuzumab vedotin (Teliso-V) is an anti–c-Met–directed antibody–drug
conjugate. Here, we present safety and efficacy data from a phase I/Ib study of Teliso-V …

Located in the west Pacific between Japan and the Philippines, the Republic of China has a
population of more than 23 million people. Malignant tumors are the leading cause of death …

While first line targeted therapies are the current standard of care treatment for non-small
cell lung cancer (NSCLC) with actionable mutations, the cancer cells inevitably acquire …

Precision oncology comprises the set of strategies that aim to design the best cancer
treatment based on tumor biology. A recognized subset of patients with non‐small cell lung …

Background Capmatinib and tepotinib are guideline-recommended front-line treatments for
non-small-cell lung cancer (NSCLC) patients with MET exon 14 skipping mutations …

Lung cancer is a highly heterogeneous disease often driven by well-characterized driver
mutations. Although the best studied are common alterations in the epidermal growth factor …

Importance Although several cancer drugs receive US Food and Drug Administration (FDA)
approval each month, it is unclear how many of these cancer drugs transform the treatment …